EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of medicaid expansion with lung cancer–specific and overall mortality: A difference-in-differences analysis

Oluwasegun Akinyemi, Mojisola Fasokun, Akachukwu Eze iD, Nkemdirim Ugochukwu, Sumaiyya Arshad, Orimisan Belie, Kakra Hughes, Edward Cornwell Iii, Gal Levy

PLOS One · 2026

DOI: 10.1371/journal.pone.0332292 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Oluwasegun Akinyemi und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Clive O Callender Outcomes Research Center, Howard University College of Medicine, Washington District of Columbia, United States of America. Hauptthemen laut MEDLINE: Lung Neoplasms, Medicaid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMHD NIH HHS, National Institute on Minority Health and Health Disparities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Medicaid expansion under the Affordable Care Act (ACA) sought to improve access to timely cancer diagnosis and treatment among low‑income populations. Lung cancer remains the leading cause of cancer-related mortality in the United States, and disparities in outcomes may be sensitive to shifts in insurance coverage. This study evaluates the association between Medicaid expansion and both cancer-specific mortality and overall mortality among adults with lung cancer in California (expansion state) compared with Texas (non-expansion state).

Methods

We conducted a retrospective cohort study using SEER registry data (2007–2021) including adults aged 18–64 years diagnosed with lung cancer. The study periods were categorized as pre-ACA (2007–2013), washout year (2014), and post-ACA (2015–2021). Difference‑in‑differences (DiD) Cox proportional hazards models estimated the change in the hazard of cancer‑specific and overall mortality in California relative to Texas after Medicaid expansion, adjusting for age, sex, race/ethnicity, stage, county‑level income, and treatment. Subgroup analyses evaluated heterogeneity by race/ethnicity, disease stage, income, and treatment modality.

Results

Among 119,937 individuals with lung cancer, 52.1% resided in California and 47.8% in Texas; sample distribution remained similar across pre‑ and post‑ACA periods. Medicaid expansion was associated with an 11.9% reduction in the hazard of cancer‑specific mortality (DiD HR 0.88; 95% CI, 0.85–0.91) and an 11.4% reduction in the hazard of overall mortality (DiD HR 0.89; 95% CI, 0.86–0.91). Mortality reductions varied across subgroups. Significant improvements were observed among White, Hispanic, and Asian/Pacific Islander patients, while no statistically significant change occurred among Black patients. Greater reductions in the hazard of death were seen among patients with distant-stage disease and those residing in higher‑income areas (≥$65,000). Treatment-stratified models showed decreases in mortality among individuals receiving surgery (10.2% reduction) and chemotherapy (8.4% reduction).

Conclusion

Medicaid expansion was associated with meaningful reductions in lung cancer mortality in California relative to Texas, with benefits concentrated among several racial and clinical subgroups. Persistent null effects among Black patients highlight inequities that insurance expansion alone does not eliminate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsMedicaidHumansCaliforniaAdultMiddle AgedFemaleUnited StatesRetrospective StudiesTexasMalePatient Protection and Affordable Care ActAdolescentYoung AdultSEER ProgramInsurance CoverageProportional Hazards Models

Autor:innen und Institutionen

  • The Clive O Callender Outcomes Research Center, Howard University College of Medicine, Washington District of Columbia, United States of America.
  • Department of Epidemiology, University of Alabama at Birmingham, Alabama, United States of America.
  • Department of Surgery, Howard University College of Medicine, Washington District of Columbia, United States of America.
  • Department of Oncology and Tumor Biology, Georgetown University, Washington District of Columbia, United States of America.

ORCID-Profile: Akachukwu Eze

Förderung

  • NIMHD NIH HHS
  • National Institute on Minority Health and Health Disparities

Zitieren

APA

Akinyemi, O., Fasokun, M., Eze, A., Ugochukwu, N., Arshad, S., Belie, O., Hughes, K., Cornwell Iii, E., & Levy, G. (2026). Association of medicaid expansion with lung cancer–specific and overall mortality: A difference-in-differences analysis. PLOS One. https://doi.org/10.1371/journal.pone.0332292

Vancouver

Akinyemi O, Fasokun M, Eze A, Ugochukwu N, Arshad S, Belie O, et al. Association of medicaid expansion with lung cancer–specific and overall mortality: A difference-in-differences analysis. PLOS One. 2026. doi:10.1371/journal.pone.0332292

BibTeX
@article{Akinyemi2026,
  author = {Akinyemi, Oluwasegun and Fasokun, Mojisola and Eze, Akachukwu and Ugochukwu, Nkemdirim and Arshad, Sumaiyya and Belie, Orimisan and Hughes, Kakra and Cornwell Iii, Edward and Levy, Gal},
  title = {Association of medicaid expansion with lung cancer–specific and overall mortality: A difference-in-differences analysis},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0332292}
}
Kostenlos starten →